Renal [bpoc]
CARDIOVASCULAR [bdsy]
Steroid [strd]
Anti-Inflammatories [phsu]
COX-2 Inhibitors [orch, phsu]
Hyperkalaemia [fndg]
Renal Failure [dsyn]
Nonsteroidal Anti-inflammatory Drugs [phsu]
Hyperkalaemia [fndg]
Renal Failure [dsyn]
Complications [patf]
Cyclooxygenase 2 Inhibitors [orch, phsu]
COX-2 [aapp, enzy]
Hyperkalaemia [fndg]
Renal Failure [dsyn]
Edema [patf]
Blood Pressure [orgf]
salt retention [fndg]
Water [inch, phsu]
Responsible [fndg]
Edema [patf]
Patients [podg]
salt retention [fndg]
Water [inch, phsu]
Blood Pressure [orgf]
Decompensation [fndg]
Heart failure [dsyn]
Edema [patf]
Blood Pressure [orgf]
Reduced [qlco]
celecoxib [orch, phsu]
Compared [acty]
rofecoxib [orch, phsu]
IMPACT [gngm]
Long-term Follow-up [hlca]
CARDIOVASCULAR [bdsy]
Patients [podg]
CARDIOVASCULAR [bdsy]
Study [mnob]
Myocardial Infarction [dsyn]
rofecoxib [orch, phsu]
Probably [idcn]
High dose [qnco]
rofecoxib [orch, phsu]
Patients [podg]
included [ftcn]
Aspirin [orch, phsu]
Contra-indicated [fndg]
Study [mnob]
Suggest [idcn]
CARDIOVASCULAR [bdsy]
rofecoxib [orch, phsu]
celecoxib [orch, phsu]
Dose [qnco]
rofecoxib [orch, phsu]
mg day [qnco]
Case-Control Study [resa]
CARDIOVASCULAR [bdsy]
Identical [qlco]
celecoxib [orch, phsu]
Dose [qnco]
Increased [qnco]
Relative Risk [qnco]
1-7 [gngm]
Doses [qnco]
rofecoxib [orch, phsu]
mg day [qnco]
Cases [ftcn]
treated [topp]
Aspirin [orch, phsu]
effects [qlco]
Aspirin [orch, phsu]
Observed [ftcn]
COX-2 Inhibitors [orch, phsu]
Pharmacologic Agent [phsu]
choice [inbe]
Patients [podg]
treated [topp]
Aspirin [orch, phsu]
